Kenneth Haller - 20 May 2022 Form 3 Insider Report for Limitless X Holdings Inc. (LIMX)

Role: President, Director
Signature: /s/ Kenneth Haller
Issuer symbol: LIMX
Transactions as of: 20 May 2022
Net transactions value: $0
Form type: 3
Filing time: 29 Jul 2022, 15:54:50 UTC
Previous filing: 09 May 2022
Next filing: 31 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VYBE	Common Stock, par value $0.001 per share						3,880,000	20 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 20, 2022, pursuant to a Share Exchange Agreement dated May 11, 2022 (the "Agreement") by and between Limitless X Holdings Inc. ("Limitless") and Bio Lab Naturals Inc. (the "Issuer"), the reporting person exchanged 2,000,000 shares of Limitless common stock ("Company Shares") for 3,880,000 shares of the common stock of the Issuer (the "Exchange Shares") with the exchange ratio being 1.94 Exchange Shares for each Company Share.

Content

On May 20, 2022, pursuant to a Share Exchange Agreement dated May 11, 2022 (the "Agreement") by and between Limitless X Holdings Inc. ("Limitless") and Bio Lab Naturals Inc. (the "Issuer"), the reporting person exchanged 2,000,000 shares of Limitless common stock ("Company Shares") for 3,880,000 shares of the common stock of the Issuer (the "Exchange Shares") with the exchange ratio being 1.94 Exchange Shares for each Company Share.